A detailed history of Nuveen Asset Management, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 185,328 shares of TMDX stock, worth $14.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
185,328
Previous 164,327 12.78%
Holding current value
$14.1 Million
Previous $24.8 Million 17.56%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $2.85 Million - $3.7 Million
21,001 Added 12.78%
185,328 $29.1 Million
Q2 2024

Aug 09, 2024

BUY
$72.62 - $150.62 $5.81 Million - $12 Million
79,967 Added 94.79%
164,327 $24.8 Million
Q1 2024

May 13, 2024

SELL
$70.86 - $89.93 $155,112 - $196,856
-2,189 Reduced 2.53%
84,360 $6.24 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $71,496 - $157,781
1,946 Added 2.3%
86,549 $6.83 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $27,483 - $49,379
-514 Reduced 0.6%
84,603 $4.63 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $145,374 - $194,762
2,195 Added 2.65%
85,117 $7.15 Million
Q1 2023

May 15, 2023

SELL
$53.63 - $82.33 $658,040 - $1.01 Million
-12,270 Reduced 12.89%
82,922 $6.28 Million
Q4 2022

Feb 14, 2023

SELL
$39.08 - $64.29 $730,287 - $1.2 Million
-18,687 Reduced 16.41%
95,192 $5.88 Million
Q3 2022

Nov 14, 2022

SELL
$31.56 - $55.75 $283,124 - $500,133
-8,971 Reduced 7.3%
113,879 $4.75 Million
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $339,733 - $531,246
16,524 Added 15.54%
122,850 $3.86 Million
Q1 2022

May 16, 2022

SELL
$12.58 - $26.94 $442,627 - $947,883
-35,185 Reduced 24.86%
106,326 $2.46 Million
Q4 2021

Feb 14, 2022

SELL
$19.16 - $32.68 $17,473 - $29,804
-912 Reduced 0.64%
141,511 $2.71 Million
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $530,452 - $706,247
20,465 Added 16.78%
142,423 $4.71 Million
Q2 2021

Aug 16, 2021

SELL
$21.63 - $40.07 $1.21 Million - $2.23 Million
-55,751 Reduced 31.37%
121,958 $4.05 Million
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $1.48 Million - $3.99 Million
83,489 Added 88.61%
177,709 $7.37 Million
Q4 2020

Feb 16, 2021

SELL
$11.91 - $19.9 $7,896 - $13,193
-663 Reduced 0.7%
94,220 $1.88 Million
Q3 2020

Nov 16, 2020

BUY
$13.78 - $18.84 $290,330 - $396,939
21,069 Added 28.54%
94,883 $1.31 Million
Q2 2020

Aug 14, 2020

BUY
$11.66 - $18.26 $368,257 - $576,705
31,583 Added 74.79%
73,814 $1.32 Million
Q1 2020

May 14, 2020

BUY
$10.5 - $20.2 $462 - $888
44 Added 0.1%
42,231 $510,000
Q4 2019

Feb 14, 2020

BUY
$16.61 - $21.64 $538,429 - $701,482
32,416 Added 331.76%
42,187 $802,000
Q2 2019

Aug 15, 2019

BUY
$22.36 - $30.41 $218,479 - $297,136
9,771 New
9,771 $283,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.42B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.